Vivo Capital’s Aligos Therapeutics ALGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,199
Closed -$84.1K 43
2025
Q1
$84.1K Sell
10,199
-131,680
-93% -$2.89M 0.01% 39
2024
Q4
$5.65M Hold
141,879
0.63% 32
2024
Q3
$1.23M Sell
141,879
-2
-0% -$25 0.1% 38
2024
Q2
$1.24M Hold
141,881
0.11% 36
2024
Q1
$3.48M Hold
141,881
0.27% 38
2023
Q4
$2.36M Hold
141,881
0.19% 43
2023
Q3
$2.65M Hold
141,881
0.29% 43
2023
Q2
$3.44M Hold
141,881
0.24% 41
2023
Q1
$3.1M Hold
141,881
0.22% 38
2022
Q4
$3.38M Hold
141,881
0.39% 39
2022
Q3
$3.9M Hold
141,881
0.43% 42
2022
Q2
$4.29M Hold
141,881
0.43% 40
2022
Q1
$7.63M Hold
141,881
0.53% 36
2021
Q4
$42.1M Hold
141,881
2.54% 9
2021
Q3
$55M Hold
141,881
2.47% 10
2021
Q2
$72.3M Hold
141,881
3.13% 9
2021
Q1
$80.7M Hold
141,881
2.83% 10
2020
Q4
$98.1M Buy
+141,881
New +$69.1M 4.38% 6

Other funds holding ALGS